|
|
Structure |
Product Information |
|
AND073
Androst-2-en-17-ol, 17-methyl-, (17¦Â)- (9CI)
|
|
AND075
Androstan-17-ol, 2,3-epithio-17-methyl-, (2¦Á,3¦Á,5¦Á,17¦Â)- [4267-80-5] |
|
AND076
Androst-5-en-7-one, 3,17-dihydroxy-, (3¦Â,17¦Â)- [2226-65-5] |
|
AND077
Androst-5-en-7-one, 3,17-bis(acetyloxy)-, (3¦Â,17¦Â)- [13209-60-4] |
|
AND078
Androst-4-ene-3,17-dione [63-05-8] |
|
AND081
Androstan-17-one, 3-hydroxy-, (3¦Â,5¦Á)- [481-29-8] |
|
AND082
Androst-4-ene-3,17-dione, 11-hydroxy-, (11¦Á)- [564-33-0] |
|
AND084
Androsta-1,4-dien-3-one, 17,17'-(trithiodicarbonyl)bis[6,9-difluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)-, (6¦Á,11¦Â,16¦Á,17¦Á)-(6'¦Á,11'¦Â,16'¦Á,17'¦Á)- [960071-64-1] |
|
AND085
Androst-4-ene-17-carbonitrile, 17-hydroxy-3-oxo-, (17¦Á)- [77881-13-1] |
|
AND086
Androst-4-ene-17-carbonitrile, 17-hydroxy-3,11-dioxo-, (17¦Â)-
|
|
AND087
Androst-4-ene-3,11,17-trione [382-45-6] |
|
AND088
Androst-4-ene-17-carboxylic acid, 17-hydroxy-3,11-dioxo-, (17¦Á)- (9CI) [3597-44-2] |
|
AND089
Androsta-4,9(11)-diene-3,17-dione [1035-69-4] |
|
AND090
Androst-4-ene-3,17-dione, 11-hydroxy-, (11¦Â)- [382-44-5] |
|
AND091
Androst-4-ene-17-carboxamide, 17-hydroxy-3,11-dioxo-, (17¦Á)-
|
|
ARA002
D-arabino-Hex-1-enitol, 1,5-anhydro-2-deoxy-, 3,4,6-triacetate [2873-29-2] |
|
ARA003
D-Arabinitol, 1,4-dideoxy-5-O-[(1,1-dimethylethyl)diphenylsilyl]-1,4-epithio-3-O-(phenylmethyl)- 174833-54-6 |
|
ASC001
L-Ascorbic acid, 5,6-O-(1-methylethylidene)-2,3-bis-O-(phenylmethyl)- [2871-84-3] |
|
ASP001
L-Asparagine, N2-(ethoxycarbonyl)- [16639-91-1] |
|
ASP002
L-Aspartic acid, N-[(1,1-dimethylethoxy)carbonyl]-, 1-(1,1-dimethylethyl) ester [34582-32-6] |
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement and its liability is at buyer's risk. |
|
New products
|